Invention Grant
US08344110B2 Antibodies to thymic stromal lymphopoietin (TSLP) receptor molecules and uses thereof
有权
胸腺基质淋巴细胞生成素（TSLP）受体分子的抗体及其用途
- Patent Title: Antibodies to thymic stromal lymphopoietin (TSLP) receptor molecules and uses thereof
- Patent Title (中): 胸腺基质淋巴细胞生成素（TSLP）受体分子的抗体及其用途
-
Application No.: US13156106Application Date: 2011-06-08
-
Publication No.: US08344110B2Publication Date: 2013-01-01
- Inventor: Christiaan M Saris , Ming-Shi Chang
- Applicant: Christiaan M Saris , Ming-Shi Chang
- Applicant Address: US CA Thousand Oaks
- Assignee: Amgen Inc.
- Current Assignee: Amgen Inc.
- Current Assignee Address: US CA Thousand Oaks
- Agency: Marshall, Gerstein & Borun LLP
- Main IPC: C07K16/00
- IPC: C07K16/00 ; A61K39/00 ; C12N5/00 ; C12N5/02 ; C12P21/08
Abstract:
The present invention provides Thymic Stromal Lymphopoietin Receptor (TSLPR) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing TSLPR polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with TSLPR polypeptides.
Public/Granted literature
- US20110305705A1 ANTIBODIES TO THYMIC STROMAL LYMPHOPOIETIN RECEPTOR MOLECULES AND USES THEREOF Public/Granted day:2011-12-15
Information query
